View Full Paper

Owner Consent Verified
Policy Brief 4.7

Policy And Regulation in Quantum Computing for Pharmaceutical Firms: A Comparative Perspective

8
Pages
MLA
Style
~ 8–13 mins
Reading Time
Metaverse Food Systems Epidemiology
Abstract

This policy brief investigates “Policy And Regulation in Quantum Computing for Pharmaceutical Firms: A Comparative Perspective” using a randomized controlled trial design. Through a economic lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

Policy And Regulation in Quantum Computing for Pharmaceutical Firms: A Comparative Perspective

ABSTRACT
Policy And Regulation in Quantum Computing for Pharmaceutical Firms: A Comparative Perspective is unpacked across themes: equity, risks, costs, and change enablement. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
36 Pages 4.3
Gig Economy and Human Factors And Usability among Supply Chain Managers — Post-Pandemic Lessons
Telemedicine AI Climate
View Paper
31 Pages 4.8
Edge Computing Adoption in Retail Banks: Customer Experience — Evidence from South Asia
Risk UX DevSecOps
View Paper
11 Pages 4.8
5G Networks for Mobile Money Users: Market Entry Strategy | A time-series forecasting
MLOps Esports Epidemiology
View Paper